BDBM50548951 CHEMBL4753107::US20230365568, Compound 131

SMILES Fc1ccc2c(c1)c(=O)n(CCCNC(=O)Cc1ccccc1C(F)(F)F)c1n[nH]c(=S)n21

InChI Key InChIKey=CCASXWFAFBFAEM-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50548951   

TargetSerine/threonine-protein kinase PLK1(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50548951(CHEMBL4753107 | US20230365568, Compound 131)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of biotin-Ahx-CETFDPPLHSpTAI-NH2 binding to recombinant human full-length HA-EGFP-tagged Plk1 PBD expressed in HEK293A cells preincubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PLK1(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50548951(CHEMBL4753107 | US20230365568, Compound 131)
Affinity DataIC50: 1.40E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2024
Entry Details
US Patent